nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Memantine—Alzheimer's disease	0.371	1	CbGbCtD
Ezogabine—Dysphasia—Donepezil—Alzheimer's disease	0.0127	0.0343	CcSEcCtD
Ezogabine—KCNQ5—forebrain—Alzheimer's disease	0.00845	0.102	CbGeAlD
Ezogabine—KCNQ3—forebrain—Alzheimer's disease	0.00678	0.0819	CbGeAlD
Ezogabine—KCNQ2—forebrain—Alzheimer's disease	0.00624	0.0754	CbGeAlD
Ezogabine—KCNQ3—telencephalon—Alzheimer's disease	0.00624	0.0753	CbGeAlD
Ezogabine—KCNQ2—telencephalon—Alzheimer's disease	0.00574	0.0693	CbGeAlD
Ezogabine—Aphasia—Galantamine—Alzheimer's disease	0.00553	0.0149	CcSEcCtD
Ezogabine—Raised liver function tests—Memantine—Alzheimer's disease	0.00547	0.0147	CcSEcCtD
Ezogabine—Raised liver function tests—Rivastigmine—Alzheimer's disease	0.00535	0.0144	CcSEcCtD
Ezogabine—Hypokinesia—Galantamine—Alzheimer's disease	0.00531	0.0143	CcSEcCtD
Ezogabine—Balance disorder—Memantine—Alzheimer's disease	0.00462	0.0124	CcSEcCtD
Ezogabine—KCNQ5—nervous system—Alzheimer's disease	0.00459	0.0554	CbGeAlD
Ezogabine—Balance disorder—Rivastigmine—Alzheimer's disease	0.00452	0.0122	CcSEcCtD
Ezogabine—Nephrolithiasis—Galantamine—Alzheimer's disease	0.00446	0.012	CcSEcCtD
Ezogabine—KCNQ4—cerebellum—Alzheimer's disease	0.00444	0.0536	CbGeAlD
Ezogabine—KCNQ5—central nervous system—Alzheimer's disease	0.00442	0.0533	CbGeAlD
Ezogabine—Aphasia—Donepezil—Alzheimer's disease	0.00429	0.0115	CcSEcCtD
Ezogabine—Myoclonus—Memantine—Alzheimer's disease	0.0042	0.0113	CcSEcCtD
Ezogabine—Hypokinesia—Donepezil—Alzheimer's disease	0.00412	0.0111	CcSEcCtD
Ezogabine—Myoclonus—Rivastigmine—Alzheimer's disease	0.00411	0.011	CcSEcCtD
Ezogabine—Encephalopathy—Memantine—Alzheimer's disease	0.00393	0.0106	CcSEcCtD
Ezogabine—Nystagmus—Donepezil—Alzheimer's disease	0.00389	0.0105	CcSEcCtD
Ezogabine—Aphasia—Memantine—Alzheimer's disease	0.00389	0.0105	CcSEcCtD
Ezogabine—Aphasia—Rivastigmine—Alzheimer's disease	0.00381	0.0102	CcSEcCtD
Ezogabine—Hypokinesia—Memantine—Alzheimer's disease	0.00374	0.0101	CcSEcCtD
Ezogabine—KCNQ3—nervous system—Alzheimer's disease	0.00368	0.0445	CbGeAlD
Ezogabine—Hypokinesia—Rivastigmine—Alzheimer's disease	0.00366	0.00984	CcSEcCtD
Ezogabine—KCNQ4—brain—Alzheimer's disease	0.0036	0.0435	CbGeAlD
Ezogabine—KCNQ3—central nervous system—Alzheimer's disease	0.00354	0.0428	CbGeAlD
Ezogabine—KCNQ5—brain—Alzheimer's disease	0.00351	0.0423	CbGeAlD
Ezogabine—KCNQ3—cerebellum—Alzheimer's disease	0.00346	0.0418	CbGeAlD
Ezogabine—Nystagmus—Rivastigmine—Alzheimer's disease	0.00346	0.0093	CcSEcCtD
Ezogabine—KCNQ2—nervous system—Alzheimer's disease	0.00339	0.0409	CbGeAlD
Ezogabine—KCNQ2—central nervous system—Alzheimer's disease	0.00326	0.0394	CbGeAlD
Ezogabine—KCNQ2—cerebellum—Alzheimer's disease	0.00319	0.0385	CbGeAlD
Ezogabine—Nephrolithiasis—Memantine—Alzheimer's disease	0.00314	0.00845	CcSEcCtD
Ezogabine—Skin discolouration—Donepezil—Alzheimer's disease	0.00308	0.00828	CcSEcCtD
Ezogabine—Nephrolithiasis—Rivastigmine—Alzheimer's disease	0.00307	0.00826	CcSEcCtD
Ezogabine—Dysarthria—Donepezil—Alzheimer's disease	0.00294	0.00791	CcSEcCtD
Ezogabine—Disturbance in attention—Memantine—Alzheimer's disease	0.00291	0.00784	CcSEcCtD
Ezogabine—Disturbance in attention—Rivastigmine—Alzheimer's disease	0.00285	0.00767	CcSEcCtD
Ezogabine—Gait disturbance—Donepezil—Alzheimer's disease	0.00285	0.00766	CcSEcCtD
Ezogabine—KCNQ3—brain—Alzheimer's disease	0.00281	0.034	CbGeAlD
Ezogabine—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00273	0.00736	CcSEcCtD
Ezogabine—Dysarthria—Rivastigmine—Alzheimer's disease	0.00261	0.00702	CcSEcCtD
Ezogabine—KCNQ2—brain—Alzheimer's disease	0.00259	0.0313	CbGeAlD
Ezogabine—Gait disturbance—Memantine—Alzheimer's disease	0.00259	0.00696	CcSEcCtD
Ezogabine—Coordination abnormal—Memantine—Alzheimer's disease	0.00257	0.00692	CcSEcCtD
Ezogabine—Gait disturbance—Rivastigmine—Alzheimer's disease	0.00253	0.00681	CcSEcCtD
Ezogabine—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.00252	0.00677	CcSEcCtD
Ezogabine—Urinary retention—Galantamine—Alzheimer's disease	0.00248	0.00666	CcSEcCtD
Ezogabine—Euphoric mood—Donepezil—Alzheimer's disease	0.00239	0.00643	CcSEcCtD
Ezogabine—Coma—Memantine—Alzheimer's disease	0.00231	0.00621	CcSEcCtD
Ezogabine—Coma—Rivastigmine—Alzheimer's disease	0.00226	0.00607	CcSEcCtD
Ezogabine—Dysphagia—Galantamine—Alzheimer's disease	0.00225	0.00606	CcSEcCtD
Ezogabine—Increased appetite—Donepezil—Alzheimer's disease	0.00215	0.00578	CcSEcCtD
Ezogabine—Disorientation—Memantine—Alzheimer's disease	0.00205	0.00551	CcSEcCtD
Ezogabine—Osteoarthritis—Donepezil—Alzheimer's disease	0.00202	0.00543	CcSEcCtD
Ezogabine—Psychotic disorder—Donepezil—Alzheimer's disease	0.00197	0.0053	CcSEcCtD
Ezogabine—Increased appetite—Memantine—Alzheimer's disease	0.00195	0.00525	CcSEcCtD
Ezogabine—Amnesia—Memantine—Alzheimer's disease	0.00195	0.00525	CcSEcCtD
Ezogabine—Urinary retention—Donepezil—Alzheimer's disease	0.00192	0.00516	CcSEcCtD
Ezogabine—Haematuria—Galantamine—Alzheimer's disease	0.00191	0.00515	CcSEcCtD
Ezogabine—Amnesia—Rivastigmine—Alzheimer's disease	0.00191	0.00513	CcSEcCtD
Ezogabine—Increased appetite—Rivastigmine—Alzheimer's disease	0.00191	0.00513	CcSEcCtD
Ezogabine—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.0019	0.00511	CcSEcCtD
Ezogabine—Liver function test abnormal—Donepezil—Alzheimer's disease	0.00186	0.00501	CcSEcCtD
Ezogabine—Diplopia—Memantine—Alzheimer's disease	0.00183	0.00493	CcSEcCtD
Ezogabine—Osteoarthritis—Memantine—Alzheimer's disease	0.00183	0.00493	CcSEcCtD
Ezogabine—Diplopia—Rivastigmine—Alzheimer's disease	0.00179	0.00482	CcSEcCtD
Ezogabine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00179	0.00482	CcSEcCtD
Ezogabine—Hallucination—Galantamine—Alzheimer's disease	0.00179	0.00482	CcSEcCtD
Ezogabine—Psychotic disorder—Memantine—Alzheimer's disease	0.00179	0.00481	CcSEcCtD
Ezogabine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00178	0.00479	CcSEcCtD
Ezogabine—Oedema peripheral—Galantamine—Alzheimer's disease	0.00177	0.00477	CcSEcCtD
Ezogabine—Urethral disorder—Galantamine—Alzheimer's disease	0.00177	0.00475	CcSEcCtD
Ezogabine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00175	0.00471	CcSEcCtD
Ezogabine—Dysphagia—Donepezil—Alzheimer's disease	0.00174	0.00469	CcSEcCtD
Ezogabine—Influenza—Donepezil—Alzheimer's disease	0.00174	0.00469	CcSEcCtD
Ezogabine—Urinary retention—Memantine—Alzheimer's disease	0.00174	0.00469	CcSEcCtD
Ezogabine—Visual impairment—Galantamine—Alzheimer's disease	0.00174	0.00467	CcSEcCtD
Ezogabine—Urinary retention—Rivastigmine—Alzheimer's disease	0.0017	0.00459	CcSEcCtD
Ezogabine—Liver function test abnormal—Memantine—Alzheimer's disease	0.00169	0.00455	CcSEcCtD
Ezogabine—Eye disorder—Galantamine—Alzheimer's disease	0.00168	0.00453	CcSEcCtD
Ezogabine—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00166	0.00445	CcSEcCtD
Ezogabine—Dysuria—Donepezil—Alzheimer's disease	0.00163	0.00439	CcSEcCtD
Ezogabine—Weight increased—Donepezil—Alzheimer's disease	0.00159	0.00427	CcSEcCtD
Ezogabine—Dysphagia—Memantine—Alzheimer's disease	0.00158	0.00426	CcSEcCtD
Ezogabine—Influenza—Memantine—Alzheimer's disease	0.00158	0.00426	CcSEcCtD
Ezogabine—CYP2A6—cerebellum—Alzheimer's disease	0.00158	0.0191	CbGeAlD
Ezogabine—Mental disorder—Galantamine—Alzheimer's disease	0.00158	0.00425	CcSEcCtD
Ezogabine—Malnutrition—Galantamine—Alzheimer's disease	0.00157	0.00422	CcSEcCtD
Ezogabine—Infestation NOS—Donepezil—Alzheimer's disease	0.00156	0.00418	CcSEcCtD
Ezogabine—Infestation—Donepezil—Alzheimer's disease	0.00156	0.00418	CcSEcCtD
Ezogabine—Dysphagia—Rivastigmine—Alzheimer's disease	0.00155	0.00417	CcSEcCtD
Ezogabine—Muscle spasms—Galantamine—Alzheimer's disease	0.00151	0.00406	CcSEcCtD
Ezogabine—Haematuria—Donepezil—Alzheimer's disease	0.00148	0.00399	CcSEcCtD
Ezogabine—Neutropenia—Memantine—Alzheimer's disease	0.00148	0.00398	CcSEcCtD
Ezogabine—Dysuria—Memantine—Alzheimer's disease	0.00148	0.00398	CcSEcCtD
Ezogabine—Vision blurred—Galantamine—Alzheimer's disease	0.00148	0.00398	CcSEcCtD
Ezogabine—Tremor—Galantamine—Alzheimer's disease	0.00147	0.00395	CcSEcCtD
Ezogabine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00146	0.00391	CcSEcCtD
Ezogabine—Dysuria—Rivastigmine—Alzheimer's disease	0.00145	0.0039	CcSEcCtD
Ezogabine—Weight increased—Memantine—Alzheimer's disease	0.00144	0.00388	CcSEcCtD
Ezogabine—Malaise—Galantamine—Alzheimer's disease	0.00141	0.0038	CcSEcCtD
Ezogabine—Infestation NOS—Memantine—Alzheimer's disease	0.00141	0.0038	CcSEcCtD
Ezogabine—Infestation—Memantine—Alzheimer's disease	0.00141	0.0038	CcSEcCtD
Ezogabine—Weight increased—Rivastigmine—Alzheimer's disease	0.00141	0.00379	CcSEcCtD
Ezogabine—Vertigo—Galantamine—Alzheimer's disease	0.00141	0.00379	CcSEcCtD
Ezogabine—Syncope—Galantamine—Alzheimer's disease	0.00141	0.00378	CcSEcCtD
Ezogabine—Hallucination—Donepezil—Alzheimer's disease	0.00139	0.00374	CcSEcCtD
Ezogabine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00138	0.00372	CcSEcCtD
Ezogabine—Infestation—Rivastigmine—Alzheimer's disease	0.00138	0.00372	CcSEcCtD
Ezogabine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00138	0.00371	CcSEcCtD
Ezogabine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00138	0.00371	CcSEcCtD
Ezogabine—Oedema peripheral—Donepezil—Alzheimer's disease	0.00138	0.0037	CcSEcCtD
Ezogabine—Urethral disorder—Donepezil—Alzheimer's disease	0.00137	0.00368	CcSEcCtD
Ezogabine—Haematuria—Memantine—Alzheimer's disease	0.00135	0.00362	CcSEcCtD
Ezogabine—Visual impairment—Donepezil—Alzheimer's disease	0.00135	0.00362	CcSEcCtD
Ezogabine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00134	0.00359	CcSEcCtD
Ezogabine—Anxiety—Galantamine—Alzheimer's disease	0.00133	0.00358	CcSEcCtD
Ezogabine—Discomfort—Galantamine—Alzheimer's disease	0.00132	0.00355	CcSEcCtD
Ezogabine—Haematuria—Rivastigmine—Alzheimer's disease	0.00132	0.00354	CcSEcCtD
Ezogabine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00131	0.00351	CcSEcCtD
Ezogabine—Dry mouth—Galantamine—Alzheimer's disease	0.00131	0.00351	CcSEcCtD
Ezogabine—Confusional state—Galantamine—Alzheimer's disease	0.00129	0.00347	CcSEcCtD
Ezogabine—CYP2A6—brain—Alzheimer's disease	0.00129	0.0155	CbGeAlD
Ezogabine—Hallucination—Memantine—Alzheimer's disease	0.00126	0.00339	CcSEcCtD
Ezogabine—Shock—Galantamine—Alzheimer's disease	0.00126	0.00339	CcSEcCtD
Ezogabine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00126	0.00338	CcSEcCtD
Ezogabine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00125	0.00337	CcSEcCtD
Ezogabine—Urinary tract disorder—Memantine—Alzheimer's disease	0.00125	0.00337	CcSEcCtD
Ezogabine—Oedema peripheral—Memantine—Alzheimer's disease	0.00125	0.00336	CcSEcCtD
Ezogabine—Urethral disorder—Memantine—Alzheimer's disease	0.00124	0.00334	CcSEcCtD
Ezogabine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00124	0.00333	CcSEcCtD
Ezogabine—Hallucination—Rivastigmine—Alzheimer's disease	0.00123	0.00332	CcSEcCtD
Ezogabine—Alopecia—Donepezil—Alzheimer's disease	0.00123	0.00332	CcSEcCtD
Ezogabine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00329	CcSEcCtD
Ezogabine—Mental disorder—Donepezil—Alzheimer's disease	0.00122	0.00329	CcSEcCtD
Ezogabine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.00122	0.00329	CcSEcCtD
Ezogabine—Visual impairment—Memantine—Alzheimer's disease	0.00122	0.00329	CcSEcCtD
Ezogabine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00327	CcSEcCtD
Ezogabine—Malnutrition—Donepezil—Alzheimer's disease	0.00122	0.00327	CcSEcCtD
Ezogabine—Visual impairment—Rivastigmine—Alzheimer's disease	0.0012	0.00322	CcSEcCtD
Ezogabine—Eye disorder—Memantine—Alzheimer's disease	0.00118	0.00319	CcSEcCtD
Ezogabine—Muscle spasms—Donepezil—Alzheimer's disease	0.00117	0.00314	CcSEcCtD
Ezogabine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00116	0.00312	CcSEcCtD
Ezogabine—Paraesthesia—Galantamine—Alzheimer's disease	0.00115	0.00309	CcSEcCtD
Ezogabine—Vision blurred—Donepezil—Alzheimer's disease	0.00115	0.00308	CcSEcCtD
Ezogabine—Tremor—Donepezil—Alzheimer's disease	0.00114	0.00306	CcSEcCtD
Ezogabine—Somnolence—Galantamine—Alzheimer's disease	0.00114	0.00306	CcSEcCtD
Ezogabine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00113	0.00303	CcSEcCtD
Ezogabine—Dyspepsia—Galantamine—Alzheimer's disease	0.00113	0.00303	CcSEcCtD
Ezogabine—Alopecia—Memantine—Alzheimer's disease	0.00112	0.00301	CcSEcCtD
Ezogabine—Mental disorder—Memantine—Alzheimer's disease	0.00111	0.00299	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00111	0.00297	CcSEcCtD
Ezogabine—Malnutrition—Memantine—Alzheimer's disease	0.0011	0.00297	CcSEcCtD
Ezogabine—Fatigue—Galantamine—Alzheimer's disease	0.0011	0.00297	CcSEcCtD
Ezogabine—Malaise—Donepezil—Alzheimer's disease	0.0011	0.00295	CcSEcCtD
Ezogabine—Alopecia—Rivastigmine—Alzheimer's disease	0.0011	0.00295	CcSEcCtD
Ezogabine—Constipation—Galantamine—Alzheimer's disease	0.00109	0.00294	CcSEcCtD
Ezogabine—Vertigo—Donepezil—Alzheimer's disease	0.00109	0.00294	CcSEcCtD
Ezogabine—Syncope—Donepezil—Alzheimer's disease	0.00109	0.00293	CcSEcCtD
Ezogabine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00109	0.00292	CcSEcCtD
Ezogabine—Malnutrition—Rivastigmine—Alzheimer's disease	0.00108	0.0029	CcSEcCtD
Ezogabine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00107	0.00287	CcSEcCtD
Ezogabine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00105	0.00284	CcSEcCtD
Ezogabine—Vision blurred—Memantine—Alzheimer's disease	0.00104	0.0028	CcSEcCtD
Ezogabine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00104	0.00279	CcSEcCtD
Ezogabine—Tremor—Memantine—Alzheimer's disease	0.00103	0.00278	CcSEcCtD
Ezogabine—Anxiety—Donepezil—Alzheimer's disease	0.00103	0.00277	CcSEcCtD
Ezogabine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00102	0.00275	CcSEcCtD
Ezogabine—Discomfort—Donepezil—Alzheimer's disease	0.00102	0.00275	CcSEcCtD
Ezogabine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00102	0.00274	CcSEcCtD
Ezogabine—Dry mouth—Donepezil—Alzheimer's disease	0.00101	0.00272	CcSEcCtD
Ezogabine—Tremor—Rivastigmine—Alzheimer's disease	0.00101	0.00272	CcSEcCtD
Ezogabine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.001	0.00269	CcSEcCtD
Ezogabine—Confusional state—Donepezil—Alzheimer's disease	0.001	0.00269	CcSEcCtD
Ezogabine—Malaise—Memantine—Alzheimer's disease	0.000995	0.00268	CcSEcCtD
Ezogabine—Vertigo—Memantine—Alzheimer's disease	0.000992	0.00267	CcSEcCtD
Ezogabine—Syncope—Memantine—Alzheimer's disease	0.00099	0.00266	CcSEcCtD
Ezogabine—Leukopenia—Memantine—Alzheimer's disease	0.000988	0.00266	CcSEcCtD
Ezogabine—Infection—Donepezil—Alzheimer's disease	0.000986	0.00265	CcSEcCtD
Ezogabine—Shock—Donepezil—Alzheimer's disease	0.000976	0.00263	CcSEcCtD
Ezogabine—Malaise—Rivastigmine—Alzheimer's disease	0.000974	0.00262	CcSEcCtD
Ezogabine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000973	0.00262	CcSEcCtD
Ezogabine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000971	0.00261	CcSEcCtD
Ezogabine—Vertigo—Rivastigmine—Alzheimer's disease	0.00097	0.00261	CcSEcCtD
Ezogabine—Loss of consciousness—Memantine—Alzheimer's disease	0.00097	0.00261	CcSEcCtD
Ezogabine—Syncope—Rivastigmine—Alzheimer's disease	0.000968	0.0026	CcSEcCtD
Ezogabine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000959	0.00258	CcSEcCtD
Ezogabine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000949	0.00255	CcSEcCtD
Ezogabine—Anxiety—Memantine—Alzheimer's disease	0.000936	0.00252	CcSEcCtD
Ezogabine—Discomfort—Memantine—Alzheimer's disease	0.000928	0.0025	CcSEcCtD
Ezogabine—Dry mouth—Memantine—Alzheimer's disease	0.000919	0.00247	CcSEcCtD
Ezogabine—Asthenia—Galantamine—Alzheimer's disease	0.000918	0.00247	CcSEcCtD
Ezogabine—Anxiety—Rivastigmine—Alzheimer's disease	0.000916	0.00246	CcSEcCtD
Ezogabine—Confusional state—Memantine—Alzheimer's disease	0.000908	0.00244	CcSEcCtD
Ezogabine—Discomfort—Rivastigmine—Alzheimer's disease	0.000908	0.00244	CcSEcCtD
Ezogabine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000899	0.00242	CcSEcCtD
Ezogabine—Infection—Memantine—Alzheimer's disease	0.000895	0.00241	CcSEcCtD
Ezogabine—Paraesthesia—Donepezil—Alzheimer's disease	0.000891	0.0024	CcSEcCtD
Ezogabine—Confusional state—Rivastigmine—Alzheimer's disease	0.000888	0.00239	CcSEcCtD
Ezogabine—Shock—Memantine—Alzheimer's disease	0.000886	0.00238	CcSEcCtD
Ezogabine—Dyspnoea—Donepezil—Alzheimer's disease	0.000884	0.00238	CcSEcCtD
Ezogabine—Nervous system disorder—Memantine—Alzheimer's disease	0.000883	0.00238	CcSEcCtD
Ezogabine—Somnolence—Donepezil—Alzheimer's disease	0.000882	0.00237	CcSEcCtD
Ezogabine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000882	0.00237	CcSEcCtD
Ezogabine—Infection—Rivastigmine—Alzheimer's disease	0.000875	0.00235	CcSEcCtD
Ezogabine—Dyspepsia—Donepezil—Alzheimer's disease	0.000873	0.00235	CcSEcCtD
Ezogabine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000871	0.00234	CcSEcCtD
Ezogabine—Shock—Rivastigmine—Alzheimer's disease	0.000867	0.00233	CcSEcCtD
Ezogabine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000864	0.00232	CcSEcCtD
Ezogabine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000863	0.00232	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000856	0.0023	CcSEcCtD
Ezogabine—Fatigue—Donepezil—Alzheimer's disease	0.000855	0.0023	CcSEcCtD
Ezogabine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000852	0.00229	CcSEcCtD
Ezogabine—Constipation—Donepezil—Alzheimer's disease	0.000848	0.00228	CcSEcCtD
Ezogabine—Dizziness—Galantamine—Alzheimer's disease	0.000846	0.00228	CcSEcCtD
Ezogabine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000817	0.0022	CcSEcCtD
Ezogabine—Paraesthesia—Memantine—Alzheimer's disease	0.000809	0.00218	CcSEcCtD
Ezogabine—Rash—Galantamine—Alzheimer's disease	0.000807	0.00217	CcSEcCtD
Ezogabine—Dermatitis—Galantamine—Alzheimer's disease	0.000806	0.00217	CcSEcCtD
Ezogabine—Dyspnoea—Memantine—Alzheimer's disease	0.000803	0.00216	CcSEcCtD
Ezogabine—Somnolence—Memantine—Alzheimer's disease	0.000801	0.00215	CcSEcCtD
Ezogabine—Dyspepsia—Memantine—Alzheimer's disease	0.000793	0.00213	CcSEcCtD
Ezogabine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000791	0.00213	CcSEcCtD
Ezogabine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000786	0.00211	CcSEcCtD
Ezogabine—Somnolence—Rivastigmine—Alzheimer's disease	0.000783	0.00211	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000778	0.00209	CcSEcCtD
Ezogabine—Fatigue—Memantine—Alzheimer's disease	0.000777	0.00209	CcSEcCtD
Ezogabine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000776	0.00209	CcSEcCtD
Ezogabine—Constipation—Memantine—Alzheimer's disease	0.00077	0.00207	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000761	0.00205	CcSEcCtD
Ezogabine—Nausea—Galantamine—Alzheimer's disease	0.00076	0.00205	CcSEcCtD
Ezogabine—Fatigue—Rivastigmine—Alzheimer's disease	0.00076	0.00204	CcSEcCtD
Ezogabine—Constipation—Rivastigmine—Alzheimer's disease	0.000754	0.00203	CcSEcCtD
Ezogabine—Feeling abnormal—Memantine—Alzheimer's disease	0.000742	0.002	CcSEcCtD
Ezogabine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000726	0.00195	CcSEcCtD
Ezogabine—Asthenia—Donepezil—Alzheimer's disease	0.000712	0.00191	CcSEcCtD
Ezogabine—Dizziness—Donepezil—Alzheimer's disease	0.000656	0.00176	CcSEcCtD
Ezogabine—Asthenia—Memantine—Alzheimer's disease	0.000646	0.00174	CcSEcCtD
Ezogabine—Asthenia—Rivastigmine—Alzheimer's disease	0.000632	0.0017	CcSEcCtD
Ezogabine—Rash—Donepezil—Alzheimer's disease	0.000625	0.00168	CcSEcCtD
Ezogabine—Dermatitis—Donepezil—Alzheimer's disease	0.000625	0.00168	CcSEcCtD
Ezogabine—Dizziness—Memantine—Alzheimer's disease	0.000596	0.0016	CcSEcCtD
Ezogabine—Nausea—Donepezil—Alzheimer's disease	0.000589	0.00159	CcSEcCtD
Ezogabine—Dizziness—Rivastigmine—Alzheimer's disease	0.000583	0.00157	CcSEcCtD
Ezogabine—Rash—Memantine—Alzheimer's disease	0.000568	0.00153	CcSEcCtD
Ezogabine—Dermatitis—Memantine—Alzheimer's disease	0.000567	0.00153	CcSEcCtD
Ezogabine—Rash—Rivastigmine—Alzheimer's disease	0.000556	0.00149	CcSEcCtD
Ezogabine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000555	0.00149	CcSEcCtD
Ezogabine—Nausea—Memantine—Alzheimer's disease	0.000535	0.00144	CcSEcCtD
Ezogabine—Nausea—Rivastigmine—Alzheimer's disease	0.000523	0.00141	CcSEcCtD
Ezogabine—KCNQ3—Axon guidance—GSK3B—Alzheimer's disease	0.000192	0.0011	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—CREB1—Alzheimer's disease	0.00019	0.00109	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—CREB1—Alzheimer's disease	0.00019	0.00109	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—LPL—Alzheimer's disease	0.000189	0.00108	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—LPL—Alzheimer's disease	0.000189	0.00108	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—PTGS1—Alzheimer's disease	0.000188	0.00107	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MEF2C—Alzheimer's disease	0.000187	0.00107	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MEF2C—Alzheimer's disease	0.000187	0.00107	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP2D6—Alzheimer's disease	0.000184	0.00105	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ATP5A1—Alzheimer's disease	0.000182	0.00104	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—AGER—Alzheimer's disease	0.000182	0.00104	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—AGER—Alzheimer's disease	0.000182	0.00104	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000181	0.00104	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000181	0.00104	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PLD3—Alzheimer's disease	0.000174	0.000995	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—Alzheimer's disease	0.000172	0.000985	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA4—Alzheimer's disease	0.00017	0.000973	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—PPARG—Alzheimer's disease	0.000169	0.000971	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HSD17B10—Alzheimer's disease	0.000166	0.000954	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Alzheimer's disease	0.000166	0.000951	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TPI1—Alzheimer's disease	0.000165	0.000943	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CHAT—Alzheimer's disease	0.000165	0.000943	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—Alzheimer's disease	0.00016	0.000918	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP46A1—Alzheimer's disease	0.00016	0.000918	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GAPDHS—Alzheimer's disease	0.00016	0.000914	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—LEP—Alzheimer's disease	0.000158	0.000906	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—LEP—Alzheimer's disease	0.000158	0.000906	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MAOB—Alzheimer's disease	0.000158	0.000904	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—HMOX1—Alzheimer's disease	0.000156	0.000894	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ND1—Alzheimer's disease	0.000155	0.000887	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GAPDH—Alzheimer's disease	0.000152	0.00087	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ATP5A1—Alzheimer's disease	0.000151	0.000867	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—A2M—Alzheimer's disease	0.000147	0.000841	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NOTCH1—Alzheimer's disease	0.000146	0.000836	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NOTCH1—Alzheimer's disease	0.000146	0.000836	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLD3—Alzheimer's disease	0.000144	0.000827	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—AGER—Alzheimer's disease	0.00014	0.000803	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HSD17B10—Alzheimer's disease	0.000138	0.000793	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—DHCR24—Alzheimer's disease	0.000138	0.00079	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—DHCR24—Alzheimer's disease	0.000138	0.00079	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—PPARG—Alzheimer's disease	0.000138	0.000789	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—PPARG—Alzheimer's disease	0.000138	0.000789	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—GSK3B—Alzheimer's disease	0.000137	0.000785	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—GSK3B—Alzheimer's disease	0.000137	0.000785	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CREB1—Alzheimer's disease	0.000136	0.000778	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CREB1—Alzheimer's disease	0.000136	0.000778	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—INS—Alzheimer's disease	0.000135	0.000774	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—INS—Alzheimer's disease	0.000135	0.000774	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—TGFB1—Alzheimer's disease	0.000134	0.000767	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP46A1—Alzheimer's disease	0.000133	0.000763	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ND1—Alzheimer's disease	0.000129	0.000737	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000129	0.000737	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ACHE—Alzheimer's disease	0.000128	0.000731	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—INPP5D—Alzheimer's disease	0.000126	0.000723	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS1—Alzheimer's disease	0.00012	0.000685	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ENO1—Alzheimer's disease	0.00012	0.000685	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—Alzheimer's disease	0.00012	0.000685	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—Alzheimer's disease	0.00012	0.000685	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA4—Alzheimer's disease	0.000117	0.000672	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA4—Alzheimer's disease	0.000117	0.000672	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP2D6—Alzheimer's disease	0.000117	0.000672	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000115	0.000657	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Alzheimer's disease	0.000114	0.000655	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—TGFB1—Alzheimer's disease	0.000111	0.000637	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—BCHE—Alzheimer's disease	0.000111	0.000637	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GAPDHS—Alzheimer's disease	0.00011	0.000632	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GAPDHS—Alzheimer's disease	0.00011	0.000632	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—DHCR24—Alzheimer's disease	0.000106	0.000609	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PLCB1—Alzheimer's disease	0.000105	0.000601	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ATP5A1—Alzheimer's disease	0.000104	0.000599	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ATP5A1—Alzheimer's disease	0.000104	0.000599	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCA1—Alzheimer's disease	0.000102	0.000583	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CHAT—Alzheimer's disease	9.97e-05	0.000571	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TPI1—Alzheimer's disease	9.97e-05	0.000571	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLD3—Alzheimer's disease	9.97e-05	0.000571	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLD3—Alzheimer's disease	9.97e-05	0.000571	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	9.97e-05	0.000571	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	9.85e-05	0.000565	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MAOB—Alzheimer's disease	9.56e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD17B10—Alzheimer's disease	9.56e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD17B10—Alzheimer's disease	9.56e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	9.34e-05	0.000535	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GAPDH—Alzheimer's disease	9.2e-05	0.000527	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP46A1—Alzheimer's disease	9.2e-05	0.000527	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP46A1—Alzheimer's disease	9.2e-05	0.000527	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA4—Alzheimer's disease	9.04e-05	0.000518	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—A2M—Alzheimer's disease	8.88e-05	0.000509	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ND1—Alzheimer's disease	8.88e-05	0.000509	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ND1—Alzheimer's disease	8.88e-05	0.000509	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARGC1A—Alzheimer's disease	8.76e-05	0.000502	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HMOX1—Alzheimer's disease	8.72e-05	0.0005	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	8.68e-05	0.000498	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—Alzheimer's disease	8.53e-05	0.000489	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—Alzheimer's disease	8.53e-05	0.000489	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GAPDHS—Alzheimer's disease	8.5e-05	0.000487	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TPI1—Alzheimer's disease	8.29e-05	0.000475	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CHAT—Alzheimer's disease	8.29e-05	0.000475	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—Alzheimer's disease	8.27e-05	0.000474	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—Alzheimer's disease	8.27e-05	0.000474	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ATP5A1—Alzheimer's disease	8.06e-05	0.000462	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—LPL—Alzheimer's disease	7.98e-05	0.000457	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MAOB—Alzheimer's disease	7.94e-05	0.000455	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	7.94e-05	0.000455	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TGFB1—Alzheimer's disease	7.83e-05	0.000449	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TGFB1—Alzheimer's disease	7.83e-05	0.000449	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ACHE—Alzheimer's disease	7.73e-05	0.000443	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLD3—Alzheimer's disease	7.68e-05	0.00044	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFB1—Alzheimer's disease	7.68e-05	0.00044	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TGFB1—Alzheimer's disease	7.68e-05	0.00044	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GAPDH—Alzheimer's disease	7.65e-05	0.000438	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—INPP5D—Alzheimer's disease	7.64e-05	0.000438	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—A2M—Alzheimer's disease	7.39e-05	0.000423	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD17B10—Alzheimer's disease	7.37e-05	0.000422	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—Alzheimer's disease	7.31e-05	0.000419	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—Alzheimer's disease	7.31e-05	0.000419	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ENO1—Alzheimer's disease	7.24e-05	0.000415	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS1—Alzheimer's disease	7.24e-05	0.000415	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—Alzheimer's disease	7.18e-05	0.000412	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2D6—Alzheimer's disease	7.1e-05	0.000407	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP46A1—Alzheimer's disease	7.09e-05	0.000406	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ND1—Alzheimer's disease	6.85e-05	0.000393	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	6.85e-05	0.000392	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BCHE—Alzheimer's disease	6.73e-05	0.000386	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CALM1—Alzheimer's disease	6.71e-05	0.000385	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOE—Alzheimer's disease	6.69e-05	0.000383	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CAV1—Alzheimer's disease	6.62e-05	0.00038	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ACHE—Alzheimer's disease	6.43e-05	0.000368	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PLCB1—Alzheimer's disease	6.35e-05	0.000364	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—INPP5D—Alzheimer's disease	6.35e-05	0.000364	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.23e-05	0.000357	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCA1—Alzheimer's disease	6.16e-05	0.000353	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ENO1—Alzheimer's disease	6.02e-05	0.000345	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS1—Alzheimer's disease	6.02e-05	0.000345	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TGFB1—Alzheimer's disease	5.92e-05	0.00034	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2D6—Alzheimer's disease	5.9e-05	0.000338	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—Alzheimer's disease	5.9e-05	0.000338	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—Alzheimer's disease	5.9e-05	0.000338	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—Alzheimer's disease	5.82e-05	0.000334	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TPI1—Alzheimer's disease	5.73e-05	0.000328	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TPI1—Alzheimer's disease	5.73e-05	0.000328	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CHAT—Alzheimer's disease	5.73e-05	0.000328	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CHAT—Alzheimer's disease	5.73e-05	0.000328	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—INS—Alzheimer's disease	5.71e-05	0.000327	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BCHE—Alzheimer's disease	5.6e-05	0.000321	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MAOB—Alzheimer's disease	5.49e-05	0.000315	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MAOB—Alzheimer's disease	5.49e-05	0.000315	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—Alzheimer's disease	5.44e-05	0.000312	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—Alzheimer's disease	5.44e-05	0.000312	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARGC1A—Alzheimer's disease	5.31e-05	0.000304	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—Alzheimer's disease	5.28e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GAPDH—Alzheimer's disease	5.28e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GAPDH—Alzheimer's disease	5.28e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLCB1—Alzheimer's disease	5.28e-05	0.000303	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.22e-05	0.000299	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.18e-05	0.000297	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCA1—Alzheimer's disease	5.12e-05	0.000293	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—A2M—Alzheimer's disease	5.1e-05	0.000293	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—A2M—Alzheimer's disease	5.1e-05	0.000293	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—Alzheimer's disease	5.01e-05	0.000287	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LPL—Alzheimer's disease	4.83e-05	0.000277	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—Alzheimer's disease	4.58e-05	0.000263	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.55e-05	0.000261	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ACHE—Alzheimer's disease	4.44e-05	0.000254	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ACHE—Alzheimer's disease	4.44e-05	0.000254	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TPI1—Alzheimer's disease	4.41e-05	0.000253	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CHAT—Alzheimer's disease	4.41e-05	0.000253	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARGC1A—Alzheimer's disease	4.41e-05	0.000253	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—Alzheimer's disease	4.39e-05	0.000252	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—INPP5D—Alzheimer's disease	4.39e-05	0.000252	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—INPP5D—Alzheimer's disease	4.39e-05	0.000252	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—Alzheimer's disease	4.35e-05	0.000249	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MAOB—Alzheimer's disease	4.23e-05	0.000243	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS1—Alzheimer's disease	4.16e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ENO1—Alzheimer's disease	4.16e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS1—Alzheimer's disease	4.16e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ENO1—Alzheimer's disease	4.16e-05	0.000238	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2D6—Alzheimer's disease	4.08e-05	0.000234	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2D6—Alzheimer's disease	4.08e-05	0.000234	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	4.07e-05	0.000233	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CALM1—Alzheimer's disease	4.07e-05	0.000233	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOE—Alzheimer's disease	4.05e-05	0.000232	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LPL—Alzheimer's disease	4.02e-05	0.00023	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAV1—Alzheimer's disease	4.01e-05	0.00023	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—A2M—Alzheimer's disease	3.93e-05	0.000225	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BCHE—Alzheimer's disease	3.87e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BCHE—Alzheimer's disease	3.87e-05	0.000222	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLCB1—Alzheimer's disease	3.65e-05	0.000209	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLCB1—Alzheimer's disease	3.65e-05	0.000209	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—Alzheimer's disease	3.62e-05	0.000207	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.58e-05	0.000205	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCA1—Alzheimer's disease	3.54e-05	0.000203	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCA1—Alzheimer's disease	3.54e-05	0.000203	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—Alzheimer's disease	3.53e-05	0.000202	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—INS—Alzheimer's disease	3.46e-05	0.000198	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACHE—Alzheimer's disease	3.42e-05	0.000196	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	3.38e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CALM1—Alzheimer's disease	3.38e-05	0.000194	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOE—Alzheimer's disease	3.37e-05	0.000193	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAV1—Alzheimer's disease	3.34e-05	0.000191	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	3.21e-05	0.000184	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ENO1—Alzheimer's disease	3.21e-05	0.000184	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	3.14e-05	0.00018	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARGC1A—Alzheimer's disease	3.05e-05	0.000175	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARGC1A—Alzheimer's disease	3.05e-05	0.000175	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—Alzheimer's disease	3.03e-05	0.000174	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—Alzheimer's disease	3.03e-05	0.000174	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—Alzheimer's disease	3.03e-05	0.000174	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BCHE—Alzheimer's disease	2.98e-05	0.000171	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—Alzheimer's disease	2.93e-05	0.000168	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—INS—Alzheimer's disease	2.88e-05	0.000165	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	2.81e-05	0.000161	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—Alzheimer's disease	2.78e-05	0.000159	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPL—Alzheimer's disease	2.78e-05	0.000159	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPL—Alzheimer's disease	2.78e-05	0.000159	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	2.73e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—Alzheimer's disease	2.52e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—Alzheimer's disease	2.5e-05	0.000143	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—Alzheimer's disease	2.5e-05	0.000143	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	2.35e-05	0.000135	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	2.34e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CALM1—Alzheimer's disease	2.33e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CALM1—Alzheimer's disease	2.33e-05	0.000134	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOE—Alzheimer's disease	2.33e-05	0.000133	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOE—Alzheimer's disease	2.33e-05	0.000133	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—Alzheimer's disease	2.31e-05	0.000132	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAV1—Alzheimer's disease	2.31e-05	0.000132	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAV1—Alzheimer's disease	2.31e-05	0.000132	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—Alzheimer's disease	2.3e-05	0.000132	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPL—Alzheimer's disease	2.14e-05	0.000123	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—Alzheimer's disease	2.03e-05	0.000116	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—Alzheimer's disease	2.03e-05	0.000116	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—INS—Alzheimer's disease	1.99e-05	0.000114	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—INS—Alzheimer's disease	1.99e-05	0.000114	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	1.93e-05	0.00011	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	1.8e-05	0.000103	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOE—Alzheimer's disease	1.79e-05	0.000103	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	1.78e-05	0.000102	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—Alzheimer's disease	1.74e-05	9.99e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—Alzheimer's disease	1.74e-05	9.99e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—Alzheimer's disease	1.59e-05	9.14e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—Alzheimer's disease	1.59e-05	9.14e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	1.56e-05	8.95e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—INS—Alzheimer's disease	1.53e-05	8.78e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—Alzheimer's disease	1.4e-05	8e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	1.34e-05	7.7e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	1.23e-05	7.04e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—Alzheimer's disease	1.16e-05	6.65e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—Alzheimer's disease	8.01e-06	4.59e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—Alzheimer's disease	8.01e-06	4.59e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	6.18e-06	3.54e-05	CbGpPWpGaD
